Announcement of China Resources Shuanghe on the Company\'s 2021 Restricted Stock Incentive Plan to reserve and grant some of the first achievements to lift the sales restriction conditions during the period of lifting the sales restrictions
China Resources Shuanghe Supervisory Board\'s Inspection Opinions on Matters Related to the 2021 Restricted Stock Incentive Plan
Legal Opinion of Beijing Zhonglun Law Firm on the Reserved Part of China Resources Shuanghe\'s 2021 Restricted Stock Incentive Plan, Release the Sales Restriction Period, Achievements, and Repurchase and Cancellation of the Restricted Shares that have been granted but have not yet been lifted
China Resources Shuanghe\'s announcement on the company\'s repurchase and cancellation of some restricted stocks that have been granted incentives but sales restrictions have not yet been lifted
Legal Opinion of Beijing Zhonglun Law Firm on the Partial Cancellation of Restricted Stock Repurchase of China Resources Double-Crane Pharmaceutical Co., Ltd.'s 2021 Restricted Stock Incentive Plan
Announcement of China Resources Double-crane Pharmaceutical on the repurchase and cancellation of restricted stocks and adjustment of repurchase price under the company's 2021 Restricted Stock Incentive Plan
China Resources Double-Crane Pharmaceutical Announcement on the Profit Distribution Plan for the First Half of 2024
Legal Opinion of Zhong Lun Law Firm on the Implementation of Cancellation of Restricted Stocks Repurchased under the Restricted Stock Incentive Plan of China Resources Double-Crane Pharmaceutical Co., Ltd. in 2021.
China Resources Double-Crane Pharmaceutical's announcement on the implementation of restricted stock incentive plan repurchase and cancellation in 2021
China Resources Double-Crane Pharmaceutical 2023 Annual Equity Distribution Implementation Announcement
Announcement of China Resources Double-Crane Pharmaceutical's adjustment to the total amount of cash dividends for 2023 profit distribution.
China Resources Shuanghe Announces the First Grant of the Company\'s 2021 Restricted Stock Incentive Plan to Release the First Release of the Sales Restriction Period and Restricted Stock Listing
Announcement of China Resources Shuanghe on the Company's 2021 Restricted Stock Incentive Plan to repurchase and cancel some restricted shares
Legal opinion from Beijing Zhonglun Law Firm on China Resources Shuanghe's 2021 Restricted Stock Incentive Plan for the first time to grant some of the first restricted shares to be lifted, the sales restrictions were lifted, and the partial repurchase and
Announcement of China Resources Shuanghe on the Company's 2021 Restricted Stock Incentive Plan for the first time granting some of the first achievements in lifting the sales restriction period and lifting the sales restriction conditions
China Resources Shuanghe Supervisory Board's Inspection Opinions on Matters Related to the 2021 Restricted Stock Incentive Plan
China Resources Shuanghe Announces 2023 Profit Distribution Plan
Legal Opinion of Beijing Zhonglun Law Firm on the Implementation of Partially Restricted Stock Repurchase and Cancellation of China Resources Shuanghe Pharmaceutical Co., Ltd.'s 2021 Restricted Stock Incentive Plan
China Resources Shuanghe's Announcement on the Implementation of Repurchase and Cancellation of the 2021 Restricted Stock Incentive Plan
Announcement of China Resources Shuanghe on the acquisition of 100% shares and related transactions of China Resources Zizhu Pharmaceutical Co., Ltd.
No Data
No Data